SCHEMBL1033184

SCHEMBL1033184

Nc1ncc(C2CCCCC2)c(-c2cccc(OC(F)(F)F)c2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.45
▸ PDE4A P27815 2/20 0.44
▸ PDE4B Q07343 2/20 0.44
▸ PDE4D Q08499 2/20 0.44
▸ PDE4C Q08493 1/20 0.44
▸ ATR Q13535 1/20 0.44
▸ FEN1 P39748 3/20 0.43
▸ ALOX5AP P20292 1/20 0.43
▸ TNK2 Q07912 1/20 0.42
▸ ADORA2A P29274 2/20 0.42
▸ ADORA1 P30542 2/20 0.42
▸ BTK Q06187 1/20 0.41
▸ XDH P47989 1/20 0.41
▸ PDE10A Q9Y233 1/20 0.41
▸ DHODH Q02127 1/20 0.41
▸ PIM1 P11309 1/20 0.40
▸ PIM2 Q9P1W9 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ KCNH2 Q12809 2/20 0.40
▸ KCNA5 P22460 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3618779 0.85 ADORA2A (0.59) FEN1ALOX5APADORA2AADORA1HRH2
SCHEMBL3412298 0.82 DHFR (0.47) DHFRATRFEN1ALOX5APTNK2
SCHEMBL1030372 0.81 DHFR (0.46) DHFRFEN1ALOX5APADORA2AADORA1
SCHEMBL29655604 0.72 DHFR (0.59) DHFRATRADORA2AADORA1BTK
SCHEMBL1389085 0.72 DHFR (0.59) DHFRATRADORA2AADORA1BTK
SCHEMBL2320490 0.71 ADORA2A (0.65) ATRADORA2AADORA1
SCHEMBL3620507 0.71 TNK2 (0.47) DHFRFEN1TNK2HRH3
SCHEMBL28757182 0.71 XDH (0.49) DHFRPDE4BATRADORA2AADORA1
SCHEMBL1034532 0.70 GALR2 (0.51) PIM1PIM2KCNH2
SCHEMBL1033888 0.68 GABBR2 (0.51) DHFRFEN1ALOX5APTNK2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 — — WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 — — WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 — — WO disclosed
Send feedback